期刊文献+

特发性肺纤维化免疫因素研究进展 被引量:3

Progress on immunological factors .in idiopathic pulmonary fibrosis
原文传递
导出
摘要 特发性肺纤维化(IPF)至今发病机制不明,然而免疫因素的异常近年来逐渐被阐明,认为IPF是一种免疫相关疾病,免疫失衡在肺纤维化发生发展中起着重要作用。对IPF患者免疫因素的研究将有望为临床病情监测、治疗指导、疗效判定等提供思路。 The pathogenesis of idiopathic pulmonary fibrosis is still unclear. However, more and more researches have gradually indicated that the abnormal immune factors are much related to its pathogenesis and progress. Study profoundly on its immune factors would benefit to disease observation, treatment, and outcome.
出处 《国际呼吸杂志》 2014年第4期299-302,共4页 International Journal of Respiration
关键词 特发性肺纤维化 免疫 细胞因子 Idiopathic pulmonary fibrosis Immunology Cytokine
  • 相关文献

参考文献34

  • 1Agostini C,Semenzato G. Immunology of idiopathic pulmonary fibrosis[J].Current Opinion in Pulmonary Medicine,1996.364-369.
  • 2Rogan MP,Geraghty P,Greene CM. Antimicrobial proteins and polypeptides in pulmonary innate defence[J].RESPIRATORY RESEARCH,2006.29.
  • 3Tsoumakidou M,Bouloukaki I,Thimaki K. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis[J].EXPERIMENTAL LUNG RESEARCH,2010.373-380.
  • 4Takahashi H,Sano H,Chiba H. Pulmonary surfactant proteins A and D:innate immune functions and biomarkers for lung diseases[J].Current Pharmaceutical Design,2006.589-598.
  • 5Kishore U,Bernal AL,Kamran MF. Surfactant proteins SP-A and SP-D in human health and disease[J].Archivum Immunologiae et Therapiae Experimentalis,2005.399-417.
  • 6Ohnishi H,Yokoyama A,Kondo K. Comparative study of KL-6,surfactant protein-A,surfactant protein-D,and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases[J].American Journal of Respiratory and Critical Care Medicine,2002.378-381.
  • 7Silveyra P,Floros J. Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury[J].Frontiers in bioscience (Landmark edition),2012.407-429.
  • 8Wallace WA,Ramage EA,Lamb D. A type 2 (Th2 like) pattern of immune response predominates in the pulmonary interstitium of patients withcryptogenic fibrosing alveolitis (CFA)[J].Clinical & Experimental Immunology,1995.436-441.
  • 9Agostini C,Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis[J].Proceedings of the American Thoracic Society,2006.357-363.
  • 10孔琪,秦川.肺纤维化的发病机制及关键靶点[J].国外医学(呼吸系统分册),2005,25(5):331-333. 被引量:34

二级参考文献47

共引文献87

同被引文献32

  • 1特发性肺纤维化诊断及治疗(试行方案)[J].中华结核和呼吸杂志,1994,17(1):8-8. 被引量:103
  • 2肖洋,高洁.特发性肺纤维化的治疗进展[J].临床肺科杂志,2007,12(2):155-156. 被引量:6
  • 3Mehzer EB, Noble PW. Idiopathic pulmonary fibrosis [ J]. Orpha- net J Rare Dis,2008,3:8-9.
  • 4Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis [ J]. Clin Epidemio1,2013 ,5 :483492.
  • 5Isra 1-Biet D, Juvin K, Dang Tran K, et al. Idiopathic pulmonary fibrosis:Diagnosis and treatment in 2013 [ J]. Rev Pneumol Clin, 2014,70(1-2) :108-117.
  • 6Borensztajn K, Crestani B, Kolb M. Idiopathic pulmonary fibrosis : from epithelial injury to biomarkers-insights from the bench side [ J ]. Respiration, 2013,86 ( 6 ) :441 452.
  • 7Redente EF, Keith RC, Janssen W, et al. TNF-c: accelerates the resolution of established pulmonary fibrosis in mice by targeting pro-fibrotic lung macrophages [ J ]. Am J Respir Cell Mol Biol, 2014,50(4) :825-837.
  • 8Behr J. The diagnosis and treatment of idiopathic pulmonary fibro- sis [ J ]. Dtsch Arztebl Int,2013,110 ( 51-52 ) : 875-881.
  • 9Tamanna S, Ullah MI. Use of non-invasive ventilation in general ward for the treatment of respiratory failure[ J]. J Miss State MedAssoe ,2011,52 (9) :278-281.
  • 10Yokoyama T, Tsushima K, Yamamoto H, et al. Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive? interstitial pneumonia [ J ]. Respirology, 2012,17(2) :315-321.

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部